Treatment of halo naevus with the topical Janus kinase inhibitor tofacitinib 1.5%
Clinical and Experimental Dermatology, EarlyView.
Source: Clinical And Experimental Dermatology - Category: Dermatology Authors: W. T. Hu
,
F. Q. Lin
,
A. E. Xu Source Type: research
More News: Dermatology | Skin